Insiders Bullish on Certain Holdings of ARKG

by admin | 01/28/2022, 08:59

A look at the weighted underlying holdings of the ARK Genomic Revolution ETF (ARKG) shows an impressive 12.0% of holdings on a weighted basis have experienced insider buying within the past six months.

Verve Therapeutics Inc (Symbol: VERV), which makes up 1.12% of the ARK Geno

Weak Jobs Report Stalls Market Momentum by Knowledge Resources
Volatility Closes Below 15 by Knowledge Resources
Record Highs and Overbought Conditions Remain in Focus by Knowledge Resources
Volatility Spikes On Fed Drama by Knowledge Resources
Second-Quarter Earnings Season Gets Underway by Knowledge Resources